• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor.

作者信息

Delafosse Marion, Ponlot Eléonore, Hanset Nicolas, Estève Emmanuel, Boffa Jean-Jaques, Dahan Karine

机构信息

Department of Nephrology, Tenon Hospital, Paris, France.

Sorbonne Université, Institut national de la santé et de la recherche médicale (National Institute of Health and Medical Research in France) UMRS 1155, Tenon Hospital, Paris, France.

出版信息

Kidney Int Rep. 2020 Jul 15;5(9):1611-1612. doi: 10.1016/j.ekir.2020.06.040. eCollection 2020 Sep.

DOI:10.1016/j.ekir.2020.06.040
PMID:32954089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7486175/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e9/7486175/07acc0a8973d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e9/7486175/07acc0a8973d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e9/7486175/07acc0a8973d/gr1.jpg

相似文献

1
Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor.在磷脂酶A2受体时代，血清白蛋白对预测膜性肾病的预后仍具有重要意义。
Kidney Int Rep. 2020 Jul 15;5(9):1611-1612. doi: 10.1016/j.ekir.2020.06.040. eCollection 2020 Sep.
2
Clinical significance of Mtype phospholipase A2 receptor and thrombospondin Type 1 domaincontaining 7A in primary membranous nephropathy.M型磷脂酶A2受体和含血小板反应蛋白1结构域7A在原发性膜性肾病中的临床意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jun 28;45(6):693-700. doi: 10.11817/j.issn.1672-7347.2020.190109.
3
Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experience.原发性膜性肾病患者血清抗M型磷脂酶A2受体抗体的患病率：单中心经验
Indian J Nephrol. 2016 Jul-Aug;26(4):257-61. doi: 10.4103/0971-4065.160334.
4
Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.磷脂酶 A2 受体抗体 IgG4 亚类提高特发性膜性肾病诊断的敏感性和特异性。
Kidney Blood Press Res. 2019;44(4):848-857. doi: 10.1159/000500456. Epub 2019 Jun 26.
5
Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.两种不同免疫抑制方案治疗的特发性膜性肾病患者中M型磷脂酶A2受体抗体滴度动态变化的预后价值
Biomarkers. 2015 Feb;20(1):77-83. doi: 10.3109/1354750X.2014.993708. Epub 2014 Dec 18.
6
[Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].肾磷脂酶A2受体及血清抗磷脂酶A2受体抗体在膜性肾病中的诊断价值
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Apr 28;42(4):395-399. doi: 10.11817/j.issn.1672-7347.2017.04.005.
7
Serum secretory phospholipase A2 group IB correlates with the severity of membranous nephropathy.血清分泌型磷脂酶 A2 组 IB 与膜性肾病的严重程度相关。
Clin Chim Acta. 2018 Jul;482:178-184. doi: 10.1016/j.cca.2018.04.009. Epub 2018 Apr 9.
8
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.肾小球中 M 型磷脂酶 A2 受体的表达增强与原发性膜性肾病患者血清受体抗体相关。
Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.
9
Detection and clinical significance of glomerular M-type phospholipase A receptor in patients with idiopathic membranous nephropathy.特发性膜性肾病患者肾小球 M 型磷脂酶 A 受体的检测及临床意义。
Intern Med J. 2016 Nov;46(11):1318-1322. doi: 10.1111/imj.13233.
10
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).抗 M 型磷脂酶 A2 受体（PLA2R）自身抗体在特发性膜性肾病（IMN）监测疾病活动中的临床意义。
Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23.

引用本文的文献

1
A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy.特发性膜性肾病患者肾脏结局的动态在线列线图预测模型。
BMC Med Inform Decis Mak. 2024 Jun 19;24(1):173. doi: 10.1186/s12911-024-02568-2.

本文引用的文献

1
Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy.部分缓解时的血清白蛋白可预测膜性肾病的预后。
Kidney Int Rep. 2020 Mar 4;5(5):706-717. doi: 10.1016/j.ekir.2020.02.1030. eCollection 2020 May.
2
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.利妥昔单抗治疗重度膜性肾病：一项为期6个月的试验及延长随访
J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.
3
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.
抗磷脂酶A2受体抗体滴度可预测利妥昔单抗治疗后膜性肾病的疗效。
J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24.
4
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.